Infokiri
| Dokumendiregister | Terviseamet |
| Viit | 8.1-2/24/3125-1 |
| Registreeritud | 21.03.2024 |
| Sünkroonitud | 26.03.2024 |
| Liik | Sissetulev dokument |
| Funktsioon | 8.1 Nakkushaiguste seire, ennetuse ja tõrje korraldamine |
| Sari | 8.1-2 Nakkushaiguste epidemioloogiaalane riigiväline kirjavahetus |
| Toimik | 8.1-2/2024 |
| Juurdepääsupiirang | Avalik |
| Juurdepääsupiirang | |
| Adressaat | ECDC respiratory viruses |
| Saabumis/saatmisviis | ECDC respiratory viruses |
| Vastutaja | Kärt Sõber (TA, Peadirektori asetäitja (1) vastutusvaldkond, Nakkushaiguste epidemioloogia osakond) |
| Originaal | Ava uues aknas |
Failid
|
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. |
ECDC NORMAL
To: Operational Contact Points for Influenza, COVID-19 and SARI
Cc: National Focal Points for Viral Respiratory Diseases, National Focal Points for Surveillance, National Coordinators
Dear colleagues,
The ERVISS Feedback Survey will close in four days, and we are waiting to hear from you. Submit your feedback today: https://ec.europa.eu/eusurvey/runner/ERVISSFeedbackSurvey2024
Length of survey: 20 questions
Time required: 10-15 minutes
Deadline : 25 March
Impact: Your insights will directly inform our efforts to improve ERVISS! Share your experience of using ERVISS and any thoughts for on missing features.
Don't miss the chance to tell us what you think of ERVISS! Please share the link to the survey with other colleagues using ERVISS.
Kind regards,
The ECDC and WHO Europe respiratory virus surveillance teams
|
From: ECDC respiratory viruses
Sent: Monday, March 11, 2024 2:41 PM
Cc: ECDC Info <[email protected]>
Subject: FOR ACTION: ERVISS User Feedback Survey 2024
To: Operational Contact Points for Influenza, COVID-19 and SARI
Cc: National Focal Points for Viral Respiratory Diseases, National Focal Points for Surveillance, National Coordinators
Dear colleagues,
The European Centre for Disease Prevention and Control (ECDC) and WHO Regional Office for Europe have jointly developed the European Respiratory Virus Surveillance Summary (ERVISS). To improve ERVISS, ECDC and WHO Euro are launching a user survey to collect feedback on ERVISS: https://ec.europa.eu/eusurvey/runner/ERVISSFeedbackSurvey2024
The survey consists of 20 questions and should take 10-15 minutes to complete. Your feedback is very valuable to us as we continue to improve ERVISS. The deadline for completing the survey is 25 March.
The survey is an opportunity to provide overall feedback on ERVISS as well as input on any missing aspects and features. Each user is encouraged to complete their own survey, and we invite you to extend this invitation to any internal colleagues using ERVISS.
Thank you in advance for your feedback. Your insights will directly inform our efforts to improve ERVISS.
Kind regards,
The ECDC and WHO Europe respiratory virus surveillance teams
Confidentiality Notice
If you are not the intended recipient of this message, you are hereby kindly requested, to, consecutively, refrain from disclosing its content to any third party, delete it and inform its sender of the erroneous transmittal.
